Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Semler Scientific Inc (SMLR)

  • Business News
  • Oct. 27, 2025, 07:12 UTC
  • 0
  • 0 comments

Semler Scientific, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SMLR

Market reaction Comment Full text

Semler Scientific Inc (SMLR)

  • Business News
  • Oct. 27, 2025, 07:07 UTC
  • 0
  • 0 comments

SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text

LifeMD Inc (LFMD)

  • Business News
  • Oct. 27, 2025, 07:04 UTC
  • 0
  • 0 comments

LifeMD, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - LFMD

Market reaction Comment Full text

Incyte Corporation (INCY)

  • Business News
  • Oct. 27, 2025, 02:02 UTC
  • 0
  • 0 comments

Incyte kündigt neue Daten aus der Phase-3b-Studie TRuE-AD4 zu Opzelura® (Ruxolitinib-Creme) bei Erwachsenen mit mittelschwerer atopischer Dermatitis an

Market reaction Comment Full text

Genenta Science SpA (GNTA)

  • Business News
  • Oct. 27, 2025, 00:30 UTC
  • 0
  • 0 comments

Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares

Market reaction Comment Full text

Biogen Inc (BIIB)

  • Business News
  • Oct. 26, 2025, 23:30 UTC
  • 0
  • 0 comments

Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease

Market reaction Comment Full text

Vivani Medical Inc. (VANI)

  • Business News
  • Oct. 26, 2025, 23:15 UTC
  • 0
  • 0 comments

Vivani Medical, Inc. Announces Pricing of Common Stock Offering

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Oct. 26, 2025, 22:38 UTC
  • 0
  • 0 comments

Annual Report to Shareholders

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Oct. 26, 2025, 22:23 UTC
  • 0
  • 0 comments

Notice of Annual General Meeting and Proxy Form

Market reaction Comment Full text

Mesoblast Limited (MESO)

  • Business News
  • Oct. 26, 2025, 22:16 UTC
  • 0
  • 0 comments

Appendix 4G and Corporate Governance Statement

Market reaction Comment Full text
  • Previous
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next

Search

News categories

  • Technical Exchange News(10270)
  • Event(1436)
  • SEC News(174338)
  • FDA Approval(9614)
  • Company Report(721)
  • Business News(117058)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin